BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 14583935)

  • 1. Local oestrogen for vaginal atrophy in postmenopausal women.
    Suckling J; Lethaby A; Kennedy R
    Cochrane Database Syst Rev; 2003; (4):CD001500. PubMed ID: 14583935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local oestrogen for vaginal atrophy in postmenopausal women.
    Suckling J; Lethaby A; Kennedy R
    Cochrane Database Syst Rev; 2006 Oct; (4):CD001500. PubMed ID: 17054136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local oestrogen for vaginal atrophy in postmenopausal women.
    Lethaby A; Ayeleke RO; Roberts H
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001500. PubMed ID: 27577677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy.
    Ayton RA; Darling GM; Murkies AL; Farrell EA; Weisberg E; Selinus I; Fraser ID
    Br J Obstet Gynaecol; 1996 Apr; 103(4):351-8. PubMed ID: 8605133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Suckling J; Barlow D; Farquhar CM; Jepson RG; Roberts H
    Cochrane Database Syst Rev; 2004; (3):CD000402. PubMed ID: 15266429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
    Rioux JE; Devlin C; Gelfand MM; Steinberg WM; Hepburn DS
    Menopause; 2000; 7(3):156-61. PubMed ID: 10810960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
    Crandall C
    J Womens Health (Larchmt); 2002 Dec; 11(10):857-77. PubMed ID: 12626086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17β-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
    Rioux JE; Devlin MC; Gelfand MM; Steinberg WM; Hepburn DS
    Menopause; 2018 Nov; 25(11):1208-1213. PubMed ID: 30358715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women.
    Perrotta C; Aznar M; Mejia R; Albert X; Ng CW
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005131. PubMed ID: 18425910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women.
    Ismail SI; Bain C; Hagen S
    Cochrane Database Syst Rev; 2010 Sep; (9):CD007063. PubMed ID: 20824855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study.
    Manonai J; Theppisai U; Suthutvoravut S; Udomsubpayakul U; Chittacharoen A
    J Obstet Gynaecol Res; 2001 Oct; 27(5):255-60. PubMed ID: 11776507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.
    Henriksson L; Stjernquist M; Boquist L; Alander U; Selinus I
    Am J Obstet Gynecol; 1994 Sep; 171(3):624-32. PubMed ID: 8092207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy.
    Portman D; Shulman L; Yeaw J; Zeng S; Uzoigwe C; Maamari R; Iyer NN
    Menopause; 2015 Nov; 22(11):1197-203. PubMed ID: 25944522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial.
    Melisko ME; Goldman ME; Hwang J; De Luca A; Fang S; Esserman LJ; Chien AJ; Park JW; Rugo HS
    JAMA Oncol; 2017 Mar; 3(3):313-319. PubMed ID: 27832260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.